Aldebaran Capital’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-37,500
Closed -$112K 36
2025
Q1
$112K Buy
+37,500
New +$112K 0.11% 40